RVPHOTCPharmaceutical PreparationsFiscal year ends December 31
REVIVA PHARMACEUTICALS HOLDINGS, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$0.45−0.02 (-4.36%)
Close on Oct 19, 2026
- Market cap
- $5.94M
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
Reviva Pharmaceuticals has not reported a dividend
No dividend per share appears in Reviva Pharmaceuticals's annual filings since fiscal 2018.